Patents by Inventor Hideshi Kawakami

Hideshi Kawakami has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9894890
    Abstract: Provided are a diagnosis marker, a diagnosis method, and a therapeutic agent suitable for diagnosing and treating amyotrophic lateral sclerosis (ALS). Also provided are an animal model and a cell model suitable for developing a therapeutic agent and a treatment method for ALS. The diagnosis method for ALS includes: an isolation step in which a nucleic acid is isolated from a specimen taken from a subject; a detection step in which bases expressed in a human chromosome 10 optineurin (OPTN) gene region are detected from the isolated nucleic acid; and a determination step in which it is determined whether or not the detected bases are mutated.
    Type: Grant
    Filed: August 8, 2016
    Date of Patent: February 20, 2018
    Assignee: HIROSHIMA UNIVERSITY
    Inventors: Hideshi Kawakami, Hirofumi Maruyama, Hiroyuki Morino
  • Publication number: 20160338328
    Abstract: Provided are a diagnosis marker, a diagnosis method, and a therapeutic agent suitable for diagnosing and treating amyotrophic lateral sclerosis (ALS). Also provided are an animal model and a cell model suitable for developing a therapeutic agent and a treatment method for ALS. The diagnosis method for ALS includes: an isolation step in which a nucleic acid is isolated from a specimen taken from a subject; a detection step in which bases expressed in a human chromosome 10 optineurin (OPTN) gene region are detected from the isolated nucleic acid; and a determination step in which it is determined whether or not the detected bases are mutated.
    Type: Application
    Filed: August 8, 2016
    Publication date: November 24, 2016
    Inventors: Hideshi KAWAKAMI, Hirofumi MARUYAMA, Hiroyuki MORINO
  • Patent number: 9434992
    Abstract: Provided are a diagnosis marker, a diagnosis method, and a therapeutic agent suitable for diagnosing and treating amyotrophic lateral sclerosis (ALS). Also provided are an animal model and a cell model suitable for developing a therapeutic agent and a treatment method for ALS. The diagnosis method for ALS includes: an isolation step in which a nucleic acid is isolated from a specimen taken from a subject; a detection step in which bases expressed in a human chromosome 10 optineurin (OPTN) gene region are detected from the isolated nucleic acid; and a determination step in which it is determined whether or not the detected bases are mutated.
    Type: Grant
    Filed: March 3, 2014
    Date of Patent: September 6, 2016
    Assignee: HIROSHIMA UNIVERSITY
    Inventors: Hideshi Kawakami, Hirofumi Maruyama, Hiroyuki Morino
  • Publication number: 20140186836
    Abstract: Provided are a diagnosis marker, a diagnosis method, and a therapeutic agent suitable for diagnosing and treating amyotrophic lateral sclerosis (ALS). Also provided are an animal model and a cell model suitable for developing a therapeutic agent and a treatment method for ALS. The diagnosis method for ALS includes: an isolation step in which a nucleic acid is isolated from a specimen taken from a subject; a detection step in which bases expressed in a human chromosome 10 optineurin (OPTN) gene region are detected from the isolated nucleic acid; and a determination step in which it is determined whether or not the detected bases are mutated.
    Type: Application
    Filed: March 3, 2014
    Publication date: July 3, 2014
    Inventors: Hideshi KAWAKAMI, Hirofumi MARUYAMA, Hiroyuki MORINO
  • Publication number: 20120272345
    Abstract: Provided are a diagnosis marker, a diagnosis method, and a therapeutic agent suitable for diagnosing and treating amyotrophic lateral sclerosis (ALS). Also provided are an animal model and a cell model suitable for developing a therapeutic agent and a treatment method for ALS. The diagnosis method for ALS includes: an isolation step in which a nucleic acid is isolated from a specimen taken from a subject; a detection step in which bases expressed in a human chromosome 10 optineurin (OPTN) gene region are detected from the isolated nucleic acid; and a determination step in which it is determined whether or not the detected bases are mutated.
    Type: Application
    Filed: August 24, 2010
    Publication date: October 25, 2012
    Inventors: Hideshi Kawakami, Hirofumi Maruyama, Hiroyuki Morino